Browse by:
Research & Development

Massachusetts named most innovative state

Bloomberg Business has named Massachusetts as the most innovative state in America, just beating out Silicon Valley and California in the rankings.

AbbVie hepatitis drug granted priority review

Worcester pharmaceutical firm AbbVie has received priority review status from the U.S. Food & Drug Administration for its drug meant to treat those suffering from chronic hepatitis C virus.

Ocata tackles cornea tissue shortage

Sam Bonacci |

Marlborough-based Ocata Therapeutics is moving forward on research that could lead to a steady supply of tissue to treat diseased and injured corneas.

Former GlaxoSmithKline CEO joins Framingham biopharma board

Emily Micucci |

Jean-Pierre Garnier has been appointed chairman of the board of Alzheon Inc., a Framingham-based private biopharmaceutical startup focused on developing treatments for Alzheimer’s...

Ocata results show promise for lupus treatment

Emily Micucci |

Results published in the journal Scientific Reports suggest that Marlborough-based Ocata Therapeutics has developed technology that can be used to prevent lupus nephritis, a fatal...

WPI team creates virtual human

Emily Micucci |

Engineers at Worcester Polytechnic Institute have developed a virtual human by digitizing and combining high-resolution images of thin slices of an actual human body, WPI announced...

UMass Medical, Family Health Center receive $1M HIV grant

The U.S. Department of Health and Humans Services (HHS) on Thursday awarded a $1.03 million grant to Family Health Center of Worcester and the University of Massachusetts Medical School...

Mevion beams in on cancer treatment

CHRISTINA P. O’NEILL SPECIAL TO THE WORCESTER BUSINESS JOURNAL |

In 2007, he met with Still River Systems (renamed Mevion Medical Systems in 2011), to seek to solve the problem. He subsequently saw that the company had signed on several large providers...

Sunovion extends development agreement

Marlborough-based Sunovion Pharmaceuticals has extended a drug discovery and development agreement with a New York company.

ALS researchers at UMass Medical get ‘Ice Bucket’ funds

Katie Lannan STATE HOUSE NEWS SERVICE |

Two groups of scientists at the University of Massachusetts Medical School have each received $1 million in grant money raised during last summer's viral Ice Bucket Challenge campaign, funds that...

ADVERTISEMENTS
Copyright 2016 New England Business Media